Genetics and pancreatic disease

Current Opinion in Gastroenterology

Volumn 18, Issue 5, 2002, Pages 545-551

  Schneider, Alexander ^a   Pfützer, Roland ^a   Whitcomb, David C ^a  

^a PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; TRANSMEMBRANE CONDUCTANCE REGULATOR; TRYPSINOGEN;

ACUTE PANCREATITIS; CANCER SUSCEPTIBILITY; CHRONIC PANCREATITIS; DISEASE CLASSIFICATION; DNA MICROARRAY; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HUMAN; PANCREAS CANCER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW;

EID: 0036720002     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200209000-00004     Document Type: Review

References (59)

1. Gene mutations in children with chronic pancreatitis
2. Chronic pancreatitis: Diagnosis, classification, and new genetic developments
3. Hereditary pancreatitis: A model for understanding the genetic basis of acute and chronic pancreatitis
4. Identification of a novel pancreatitis-associated missense mutation, R116C, in the human cationic trypsinogen gene (PRSS1)
5. Cystic fibrosis gene mutations and pancreatitis risk: Relation to epithelial ion transport and trypsin inhibitor gene mutations
6. Use of DNA arrays/microarrays in pancreatic research
7. Identification of disease-specific genes in chronic pancreatitis using DNA array technology
8. Genetic predispositions to acute and chronic pancreatitis
9. An interleukin-8 microsatellite allele is associated with reduced risk of multiple organ dysfunction syndrome in severe acute pancreatitis
10. Fine genomic mapping implicates IL-10 as a severity gene in acute pancreatitis
11. TNF-a promoter region polymorphisms in patients with alcoho-induced chronic pancreatitis
12. Glutathione-S-transferase theta-1 null polymorphism is protective in acute pancreatitis
13. Cytokine gene polymorphisms in acute pancreatitis
14. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene
15. Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis
16. Molecular pathology and evolutionary and physiological implications of pancreatitis-associated cationic trypsinogen mutations
17. A new polymorphism for the R122H mutation in hereditary pancreatitis
18. Novel cationic trypsinogen (PRSS1) N29T and R122C mutations cause autosomal dominant hereditary pancreatitis
19. Hereditary pancreatitis caused by a novel PRSS1 mutation (Arg-122 ->Cys) that alters autoactivation and autodegradation of cationic trypsinogen
20. Mutational screening of patients with nonalcoholic chronic pancreatitis: Identification of further trypsinogen variants
21. A CGC>CAT gene conversion-like event resulting in the R122H mutation in the cationic trypsinogen gene and its implication in the genotyping of pancreatitis
22. Human cationic trypsinogen: Role of Asn-21 in zymogen activation and implications in hereditary pancreatitis
23. Discrimination of three mutational events that result in a disruption of the R122 primary autolysis site of the human cationic trypsinogen (PRSS1) by denaturing high performance liquid chromatography
24. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene
25. R116C mutation of cationic trypsinogen in a Turkish family with recurrent pancreatitis illustrates genetic microheterogeneity of hereditary pancreatitis
26. Expression and penetrance of the hereditary pancreatitis phenotype in monozygotic twins
27. Clinical characterization of patients with hereditary pancreatitis and mutations in the cationic trypsinogen gene
28. Clinical characteristics of hereditary pancreatitis in a large family based on high-risk haplotype
29. Pancreatic secretory enzymes
30. Mutations in the gene encoding the serine protease inhibitor, kazal type 1 are associated with chronic pancreatitis
31. SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis
32. Mutations of the pancreatic secretory trypsin inhibitor (PSTI) gene in idiopathic chronic pancreatitis
33. Analysis of the human pancreatic secretory trypsin inhibitor (PSTI) gene mutations in Japanese patients with chronic pancreatitis
34. Genetic mutations in exons 3 and 4 of the pancreatic secretory trypsin inhibitor in patients with pancreatitis
35. Low prevalence of SPINK1 gene mutations in adult patients with chronic idiopathic pancreatitis
36. High frequency of the N34S mutation in the SPINK1 gene in chronic pancreatitis detected by a new PCR-RFLP assay
37. SPINK1/PSTI mutations are associated with tropical pancreatitis in Bangladesh: A preliminary report
38. SPINK1 mutations in tropical pancreatitis and diabetes patients from Bangladesh
39. Mutations in the SPINK1 gene modify the phenotypic expression of hereditary pancreatitis caused by cationic trypsinogen (PRSS1) mutations R122H and N291
40. The N34S mutation of SPINK1 (PSTI) is associated with a familial pattern of idiopathic chronic pancreatitis but does not cause the disease
41. Mutation in the SPINK1 trypsin inhibitor gene, alcohol use, and chronic pancreatitis
42. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis
43. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis
44. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis
45. Conference report: Third International Symposium on Inherited Diseases of the Pancreas
46. Genetic testing for hereditary pancreatitis: Guidelines for indications, counselling, consent and privacy issues
47. Heredity and malignant melanoma: Implications for early cancer detection
48. Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: The familial atypical mole melanoma-pancreatic carcinoma syndrome
49. High prevalence of the G101W germline mutation in the CDKN2A (P16(ink4a)) gene in 62 Italian malignant melanoma families
50. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer
51. Familial risk of pancreatic cancer
52. Risk of pancreatic cancer among individuals with a family history of cancer of the pancreas
53. Cigarette smoking and risk of bladder, pancreas, kidney, and colorectal cancers in Iowa
54. A prospective study on active and environmental tobacco smoking and bladder cancer risk (The Netherlands)
55. Familial fibrocystic pancreatic atrophy with endocrine cell hyperplasia and pancreatic carcinoma
56. A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32-34
57. Hereditary pancreatitis and the risk of pancreatic cancer
58. Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis
59. A population-based, case-control study of polymorphisms in carcinogen-metabolizing genes, smoking, and pancreatic adenocarcinoma risk